TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19815581

Group type: EXPERIMENTAL
Intervention: Expectant management
Number of subjects: 1199

Group type: EXPERIMENTAL
Intervention: Medical management
Number of subjects: 1199

Group type: EXPERIMENTAL
Intervention: Surgical management
Number of subjects: 1199
Study: 18704870

Group type: EXPERIMENTAL
Intervention: Socio-medical intervention (EG 1)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Relaxation therapy module (EG 2)
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 206
Study: 16012177

Group type: EXPERIMENTAL
Intervention: 5-fluorouracil (5-FU) regimens
Number of subjects: 391
Study: 12474114

Group type: EXPERIMENTAL
Intervention: Ayahuasca (0.6 mg and 0.85 mg DMT/kg body weight)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 10095919

Group type: EXPERIMENTAL
Intervention: Oral antibacterial drugs for uncomplicated pneumonia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Starting regimen for nosocomial or hospital pneumonia
Number of subjects: 0
Study: 8861134

Group type: EXPERIMENTAL
Intervention: High dietary magnesium (315 mg/d)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Low dietary magnesium (115 mg/d)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: High dietary boron (3.23 mg/d)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Low dietary boron (0.23 mg/d)
Number of subjects: 13
Study: 2101950

Group type: EXPERIMENTAL
Intervention: Salbutamol via metered-dose inhaler (MDI)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Salbutamol via spacer
Number of subjects: 14
Study: 7380993

Group type: EXPERIMENTAL
Intervention: Metoclopramide (10 mg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Oral Metoclopramide (10 mg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Metoclopramide (10 mg) during dopamine infusion
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 29807495

Group type: EXPERIMENTAL
Intervention: Latina Breast Cancer Survivorship Intervention (telephone-based, 3 education sessions weekly, 6 support calls)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Support and early education (intervention group)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Support and delayed education (control group)
Number of subjects: 40
Study: 26205775

Group type: EXPERIMENTAL
Intervention: Intervention schools with policy changes and portable equipment
Number of subjects: 1582

Group type: COMPARATOR
Intervention: Control schools
Number of subjects: 1582
Study: 24854628

Group type: EXPERIMENTAL
Intervention: Pravastatin 40 mg/day
Number of subjects: 5414

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5414

Group type: EXPERIMENTAL
Intervention: ABCA1 R219K variant presence
Number of subjects: 5414
Study: 23248895

Group type: EXPERIMENTAL
Intervention: Multi-directional power toothbrush (Oral-B Professional Deep Sweep TRICLEAN 1000)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Sonic control toothbrush (Philips Sonicare Essence 5500)
Number of subjects: 130
Study: 20636719

Group type: EXPERIMENTAL
Intervention: Task-specific walking training plus targeted strength training three times per week over 10 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Task-specific walking training
Number of subjects: 0
Study: 18543584

Group type: EXPERIMENTAL
Intervention: Dexibuprofen tablets (400 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Racemic ibuprofen tablets (400 mg)
Number of subjects: 20
Study: 16633363

Group type: EXPERIMENTAL
Intervention: Immediate consolidation with high-dose chemotherapy and hematopoietic support
Number of subjects: 69

Group type: COMPARATOR
Intervention: Observation with delayed consolidation
Number of subjects: 69
Study: 12941199

Group type: EXPERIMENTAL
Intervention: Monoclonal antibodies (C225 and ABX‐EGF) and tyrosine kinase inhibitors (ZD1839 and OSI‐774)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inhibitors of farnesyl transferase (R115777 and SCH66336)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inhibitors of vascular growth factor receptor (bevacizumab and PTK787)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cyclooxygenase‐2 inhibitors in colorectal cancer and STI571 in GI stromal tumors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Novel agents administered alone or in combination with standard therapies
Number of subjects: 0
Study: 10532418

Group type: EXPERIMENTAL
Intervention: TdT‐mediated dUTP‐biotin nick‐end labeling (TUNEL) method
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Immunohistochemical expression of bcl‐2 protein
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Immunohistochemical expression of p53 protein
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Ki‐67 antibody for cell proliferative activity
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Apoptotic cell distribution in GB
Number of subjects: 25
Study: 8983318

Group type: EXPERIMENTAL
Intervention: Ramipril 2.5mg and 5mg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Enalapril 10mg and 20mg
Number of subjects: 30
Study: 1953228

Group type: EXPERIMENTAL
Intervention: Pravastatin 10 mg twice a day for 8 weeks
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Pravastatin 20 mg twice a day for an additional 8 weeks
Number of subjects: 82
Study: 7347361

Group type: EXPERIMENTAL
Intervention: Nurse-supervised education class
Number of subjects: 112

Group type: COMPARATOR
Intervention: Gastroenterologist appointments
Number of subjects: 112
Study: 30938568

Group type: EXPERIMENTAL
Intervention: Vitamin B plus GeneTimeÂ® (observation group)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Vitamin B alone (control group)
Number of subjects: 100
Study: 27561307

Group type: EXPERIMENTAL
Intervention: Instructional video demonstrating pain behavior
Number of subjects: 40

Group type: COMPARATOR
Intervention: Instructional video demonstrating a stoic response
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Cold pressor task
Number of subjects: 40
Study: 26118949

Group type: EXPERIMENTAL
Intervention: IMH-HB EHS services (n = 75)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Comparison condition (n = 77)
Number of subjects: 152
Study: 23546628

Group type: EXPERIMENTAL
Intervention: Herbal formula
Number of subjects: 740

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 740
Study: 21821513

Group type: EXPERIMENTAL
Intervention: Underbody resistive warming
Number of subjects: 70

Group type: COMPARATOR
Intervention: Forced-air warming
Number of subjects: 70
Study: 19726912

Group type: EXPERIMENTAL
Intervention: Robot pet-assisted program
Number of subjects: 32
Study: 18006923

Group type: EXPERIMENTAL
Intervention: Moderate-to-vigorous aerobic activity, 60 min/d, 6 days/wk
Number of subjects: 184

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 184
Study: 14739815

Group type: EXPERIMENTAL
Intervention: 75 microg neostigmine
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 150 microg neostigmine
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 300 microg neostigmine
Number of subjects: 80

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: All neostigmine groups (75, 150, 300 microg)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 80
Study: 11281234

Group type: EXPERIMENTAL
Intervention: nifedipine‐GITS
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: verapamil‐SR
Number of subjects: 30
Study: 9567500

Group type: EXPERIMENTAL
Intervention: Middleton's manoeuvre
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Supine palpation
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Castell's manoeuvre
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Nixon's manoeuvre
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Traube's space percussion
Number of subjects: 80
Study: 7943768

Group type: EXPERIMENTAL
Intervention: Belscope angulated straight blade
Number of subjects: 98

Group type: COMPARATOR
Intervention: Wisconsin blade
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: All blades used in Study 1 and Study 2
Number of subjects: 98
Study: 3108131

Group type: EXPERIMENTAL
Intervention: TRH (500 micrograms intravenously)
Number of subjects: 4
Study: 30767647

Group type: EXPERIMENTAL
Intervention: Jelonet Plus (JP) dressing
Number of subjects: 99

Group type: COMPARATOR
Intervention: UrgoTul (UT) dressing
Number of subjects: 99
Study: 27914297

Group type: EXPERIMENTAL
Intervention: Vildagliptin add-on therapy
Number of subjects: 73

Group type: COMPARATOR
Intervention: Conventional therapy without DPP-4 inhibitors
Number of subjects: 73
Study: 25061034

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) and stretching exercise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intramuscular electrical stimulation (IMS) and stretching exercise
Number of subjects: 0

Group type: COMPARATOR
Intervention: Stretching exercise
Number of subjects: 0
Study: 23093040

Group type: EXPERIMENTAL
Intervention: Adverse drug events (ADEs)
Number of subjects: 4032

Group type: EXPERIMENTAL
Intervention: Other drug-related problems (DRPs)
Number of subjects: 4032

Group type: EXPERIMENTAL
Intervention: Serious ADEs
Number of subjects: 4032

Group type: EXPERIMENTAL
Intervention: Unexpected ADEs
Number of subjects: 4032

Group type: EXPERIMENTAL
Intervention: Gastrointestinal tract involvement in ADEs
Number of subjects: 4032

Group type: EXPERIMENTAL
Intervention: Problems with administration and dosing of medicine
Number of subjects: 4032

Group type: EXPERIMENTAL
Intervention: DRPs related to anti-infectives
Number of subjects: 4032
Study: 21314913

Group type: EXPERIMENTAL
Intervention: Incredible Years Therapeutic Dinosaur Programme delivered in small groups for 2 hours/week for 18 weeks
Number of subjects: 240

Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Incredible Years Therapeutic Dinosaur Programme
Number of subjects: 240
Study: 18392557

Group type: EXPERIMENTAL
Intervention: Warfarin therapy with careful monitoring of INR
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 16545702

Group type: EXPERIMENTAL
Intervention: LactoSorb (n = 18)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: BioSorb (n = 18)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Delta (n = 18)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Titanium osteosynthesis (control group D: n = 15)
Number of subjects: 64
Study: 15601464

Group type: EXPERIMENTAL
Intervention: Hydrocolloid dressing (HD)
Number of subjects: 83
Study: 11346448

Group type: EXPERIMENTAL
Intervention: Flexyx Neurotherapy System (FNS)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 12
Study: 9236644

Group type: EXPERIMENTAL
Intervention: External cephalic version
Number of subjects: 243
Study: 10155208

Group type: EXPERIMENTAL
Intervention: Heparin-coated coronary stents
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Delayed deep anticoagulation
Number of subjects: 0
Study: 3038423

Group type: EXPERIMENTAL
Intervention: Captopril 25 mg twice daily
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Enalapril 2.5 to 10 mg once daily
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo therapy
Number of subjects: 7
Study: 29457671

Group type: EXPERIMENTAL
Intervention: Lofexidine and dronabinol
Number of subjects: 62
Study: 27069153

Group type: EXPERIMENTAL
Intervention: BCG instillation (one-third dose, three weekly instillations every 6 months for 3 years)
Number of subjects: 146

Group type: COMPARATOR
Intervention: BCG instillation (two weekly instillations every 3 months for 3 years)
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: NRAMP1 D543N polymorphism (allele A)
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: NRAMP1 and hGPX1 gene polymorphisms
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: NRAMP1 D543N GG genotype
Number of subjects: 146
Study: 24699259

Group type: EXPERIMENTAL
Intervention: 100 counts-per-minute (CPM) cut-point for hip placement
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Various cut-points (100 CPM, 200 CPM, 300 CPM, 500 CPM, 800 CPM, 1100 CPM) for wrist placement
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: ROC-derived cut-point for hip vector magnitude
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: ROC-derived cut-point for wrist vertical axis
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: ROC-derived cut-point for wrist vector magnitude
Number of subjects: 125
Study: 23733528

Group type: EXPERIMENTAL
Intervention: Medication diary-book
Number of subjects: 109

Group type: COMPARATOR
Intervention: Control (standard parental education program and donated chemotherapy)
Number of subjects: 109
Study: 20416246

Group type: EXPERIMENTAL
Intervention: Enema administered before surgery
Number of subjects: 162

Group type: COMPARATOR
Intervention: No enema administered (Control)
Number of subjects: 162
Study: 17588820

Group type: EXPERIMENTAL
Intervention: Vertebroplasty
Number of subjects: 168

Group type: COMPARATOR
Intervention: Kyphoplasty
Number of subjects: 168
Study: 16548361

Group type: EXPERIMENTAL
Intervention: Guchong Zhixue Decoction (GCZXD) taken orally
Number of subjects: 60

Group type: COMPARATOR
Intervention: Yigong Zhixue Oral Liquid, taken orally
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Guchong Zhixue Decoction (GCZXD)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Yigong Zhixue Oral Liquid
Number of subjects: 60
Study: 12968087

Group type: EXPERIMENTAL
Intervention: Nevirapine
Number of subjects: 460

Group type: EXPERIMENTAL
Intervention: Efavirenz
Number of subjects: 460

Group type: EXPERIMENTAL
Intervention: Abacavir
Number of subjects: 460
Study: 11135333

Group type: EXPERIMENTAL
Intervention: Exposure to appearance stereotyping and discrimination information
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control topic of television violence and aggression
Number of subjects: 66
Study: 9778550

Group type: EXPERIMENTAL
Intervention: AMI patients
Number of subjects: 18

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 18
Study: 8157777

Group type: EXPERIMENTAL
Intervention: 5% potassium nitrate dentifrice
Number of subjects: 36

Group type: COMPARATOR
Intervention: Vehicle paste (control group)
Number of subjects: 36
Study: 2901815

Group type: EXPERIMENTAL
Intervention: Oral slow release morphine 30 mg
Number of subjects: 62

Group type: COMPARATOR
Intervention: Temazepam 30 mg
Number of subjects: 62
Study: 28348380

Group type: EXPERIMENTAL
Intervention: Tetris-based intervention (trauma memory reminder cue plus approximately 20 minutes of game play)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Attention-placebo control (written activity log for the same duration)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tetris-based intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Attention-placebo control
Number of subjects: 0
Study: 28776345

Group type: EXPERIMENTAL
Intervention: Daytime solifenacin dosing
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Nighttime solifenacin dosing
Number of subjects: 127
Study: 26196952

Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass (RYGB)
Number of subjects: 21
Study: 23921652

Group type: COMPARATOR
Intervention: 3 mg epidural morphine
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 1.5 mg epidural morphine
Number of subjects: 90
Study: 20622407

Group type: EXPERIMENTAL
Intervention: Awareness of lifestyle risk factors of noncommunicable diseases (NCDs)
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: Awareness of passive smoking, early age at marriage, and reuse of cooking oil as risk factors for NCDs
Number of subjects: 375
Study: 18371466

Group type: EXPERIMENTAL
Intervention: Cypher stent (Johnson & Johnson)
Number of subjects: 2260

Group type: EXPERIMENTAL
Intervention: Vision stent (Abbott Vascular)
Number of subjects: 2260

Group type: EXPERIMENTAL
Intervention: Xience stent (Abbott Vascular)
Number of subjects: 2260

Group type: COMPARATOR
Intervention: Cobalt-chromium bare-metal stents
Number of subjects: 2260

Group type: EXPERIMENTAL
Intervention: 12-month dual antiplatelet therapy
Number of subjects: 2260
Study: 17023236

Group type: EXPERIMENTAL
Intervention: Natural Setting Behavior Management (NSBM)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Education only
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 37
Study: 14664687

Group type: EXPERIMENTAL
Intervention: Providers considered as fixed factors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Statistical power in fixed model
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Treatment effects analysis
Number of subjects: 0
Study: 10928769

Group type: EXPERIMENTAL
Intervention: LASIK (more than -5 D)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: PRK (more than -5 D)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: LASIK (less than -5 D)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: PRK (less than -5 D)
Number of subjects: 103
Study: 8751803

Group type: EXPERIMENTAL
Intervention: TAM (30 mg/day) and MPA (800 mg/day)
Number of subjects: 92

Group type: COMPARATOR
Intervention: TAM (30 mg/day)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: MPA (800 mg/day)
Number of subjects: 92

Group type: COMPARATOR
Intervention: 5-FU alone
Number of subjects: 92
Study: 1419204

Group type: EXPERIMENTAL
Intervention: Prospective diary
Number of subjects: 598

Group type: COMPARATOR
Intervention: Retrospective diary
Number of subjects: 598
Study: 30452719

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (mainly UFT)
Number of subjects: 5006

Group type: COMPARATOR
Intervention: Not applicable (non-participation in trial)
Number of subjects: 5006
Study: 28125330

Group type: EXPERIMENTAL
Intervention: Non-dominant practice (NDG; n=11)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Bilateral practice (BG; n=8)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (CG; n=11)
Number of subjects: 30
Study: 27100432

Group type: EXPERIMENTAL
Intervention: Intensified infliximab regimen for 12 weeks
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Nonimmune PK failure
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Nonimmune PK failures after 12 weeks
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Nonimmune PK failures during IFX intensification
Number of subjects: 28
Study: 24550184

Group type: EXPERIMENTAL
Intervention: Scorpion antivenom (SAV) plus prazosin
Number of subjects: 50

Group type: COMPARATOR
Intervention: Prazosin alone
Number of subjects: 50
Study: 22215277

Group type: EXPERIMENTAL
Intervention: Automated detection of dual p16/Ki67 immunoreactivity
Number of subjects: 18068
Study: 20730395

Group type: EXPERIMENTAL
Intervention: Tirofiban
Number of subjects: 301
Study: 17574466

Group type: EXPERIMENTAL
Intervention: Dual-energy X-ray absorptiometry (DXA) for measuring juxta-articular bone mineral density (BMD) at MCP joints
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Dual-energy X-ray absorptiometry (DXA) for measuring whole hand (WH) BMD
Number of subjects: 38

Group type: COMPARATOR
Intervention: Patients with rheumatoid arthritis criteria
Number of subjects: 38
Study: 16236870

Group type: EXPERIMENTAL
Intervention: Apnea Risk Evaluation System (ARES)
Number of subjects: 299

Group type: EXPERIMENTAL
Intervention: ARES (unattended at home)
Number of subjects: 299
Study: 12229970

Group type: EXPERIMENTAL
Intervention: Bisacodyl
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Polyethylene glycol
Number of subjects: 10
Study: 10441825

Group type: EXPERIMENTAL
Intervention: PLIF with Moss-Miami implants
Number of subjects: 12

Group type: COMPARATOR
Intervention: PLIF with threaded cages (BAK-cages)
Number of subjects: 12
Study: 7779349

Group type: EXPERIMENTAL
Intervention: Comprehensive early intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Number of home visits, days attended at child centers, number of parent meetings attended
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 2126002

Group type: EXPERIMENTAL
Intervention: Multi-drug combination chemotherapy (VMCP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cyclophosphamide-prednisolone (CP)
Number of subjects: 0
Study: 6999239

Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 31823503

Group type: EXPERIMENTAL
Intervention: Text messaging intervention designed to augment the BFPC program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 31093941

Group type: EXPERIMENTAL
Intervention: Clinical pharmacist led medication review using the RASP list
Number of subjects: 61

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Clinical pharmacist interventions (across three controlled studies)
Number of subjects: 61
Study: 27647465

Group type: EXPERIMENTAL
Intervention: e-learning training platform for continuous medical education
Number of subjects: 374
Study: 25847778

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Moxibustion
Number of subjects: 60
Study: 24429785

Group type: EXPERIMENTAL
Intervention: Parodontocid mouthrinse used in conjunction with normal brushing and flossing
Number of subjects: 60

Group type: COMPARATOR
Intervention: Toothbrush and prophylactic toothpaste
Number of subjects: 60
Study: 21957592

Group type: EXPERIMENTAL
Intervention: Duloxetin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pain syndrome therapy (Duloxetin and Gabapentin)
Number of subjects: 0
Study: 19620930

Group type: EXPERIMENTAL
Intervention: Caffeine (5 mg/kg body weight + 0.125 g/kg carbohydrate)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo (0.125 g/kg carbohydrate)
Number of subjects: 17
Study: 17225141

Group type: EXPERIMENTAL
Intervention: 60 mg urapidil
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 4 mg doxazosin
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 15072419

Group type: EXPERIMENTAL
Intervention: Intratympanic gentamicin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intratympanic buffer solution (placebo)
Number of subjects: 0
Study: 11724460

Group type: EXPERIMENTAL
Intervention: Dietary supplementation with marine oil or single-cell oil sources of LC-PUFA
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Docosahexaenoic acid (DHA) supplementation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: n-3 fatty acid supplementation
Number of subjects: 0